LA JOLLA PHARMA LLC has a total of 13 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SIGNPATH PHARMA INC, SHANGHAI HARVEST PHARMACEUTICAL CO LTD and FUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Tidmarsh George | 10 |
#2 | Chawla Lakhmir | 8 |
#3 | Rolke James | 2 |
#4 | Chen Steve Ching Tsung | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020252333A1 | Methods for administering angiotensin ii by monitoring renin levels | |
US2020222493A1 | Methods for administering angiotensin ii | |
AU2015287955A1 | Methods for treating hypotension |